Matthew Henke

Assistant Professor

University of Chicago
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Matthew Henke is an Assistant Professor at the University of Illinois at Chicago, USA. His research focuses on microbiology, specifically exploring the role of gut microbes in human health and their interactions with the immune system. Recent publications include studies on the bacteriocin produced by Mediterraneibacter gnavus and the immune response related to Ruminococcus gnavus, as well as investigations into natural product discovery in combating drug-resistant bacteria.

Articles (7)

Year:

2026

Year:

2026

A diverse, stable community of microbes in the human gut is strongly tied to health. The factors that regulate microbial community structure and dynamics are ill-defined. In this study, we discover mediterrocin, a bacteriocin produced by the core member of the human gut microbiota, Mediterraneibacter gnavus (previously Ruminococcus gnavus ). Following a screen for antimicrobial production by clinical isolates of M. gnavus , mediterrocin was isolated by bioactivity-guided fractionation from strain RJX1121, identified by mass spectrometry, and confirmed by gene disruption. Mediterrocin, an 89 amino acid secreted protein, is a broad-spectrum bacteriocin. Annotation of the mediterrocin biosynthetic gene cluster revealed a wide distribution among Bacillota (previously Firmicutes), including the M. gnavus type strain ATCC249149. The type strain of M. gnavus also produces mediterrocin, but in lower titers than RJX1121 under our culture conditions. Mediterrocin is inhibitory to multiple M. gnavus strains, but with varying sensitivity, with isolates from patients with inflammatory bowel disease displaying the greatest susceptibility. Beyond M. gnavus , mediterrocin demonstrated inhibitory activity against other Lachnospiraceae and the gram-negative pathogen Morganella morganii . Further characterization of mediterrocin may clarify how this core member of the healthy microbiome interacts with other community members and how the relative abundance of M. gnavus changes in microbiome dysbiosis associated with several diseases. IMPORTANCE Mediterraneibacter gnavus is a core member of the gut microbiome and implicated in several diseases. Direct competition between M. gnavus and other members of the microbiome may contribute to the shift from a diverse, structured community to dysbiosis observed in disease. Identifying molecular mechanisms of microbial competition will aid future studies of these disease-relevant bacteria and clarify how community structure is maintained. We report the discovery of mediterrocin, a bacteriocin present in many species in the orders Lachnospirales and Eubacteriales, but clade-specific within M. gnavus . Mediterrocin, produced by health-associated strains of M. gnavus , inhibits the growth of disease-associated M. gnavus strains and a broad spectrum of gut commensal bacteria and pathogens.

Year:

2025

Asymptomatic gut colonization increases the risk of clinical infection and transmission by the multidrug-resistant pathogen Acinetobacter baumannii . Ornithine utilization was shown to be critical for A. baumannii competition with the resident microbiota to persist in gut colonization, but the regulatory mechanisms and cues are unknown. Here, we identify a transcriptional regulator, AstR, that specifically activates the expression of the A. baumannii ornithine utilization operon astNOP. Phylogenetic analysis suggests that AstR was co-opted from the Acinetobacter arginine utilization ast(G)CADBE locus and is specialized to regulate ornithine utilization in A. baumannii . Reporter assays showed that astN promoter expression was activated by ornithine but inhibited by glutamate and other preferred amino acids. astN promoter expression was similarly activated by incubation with fecal samples from conventional mice but not germ-free mice, suggesting AstR-dependent activation of the astN promoter responds to intermicrobial competition for amino acids. Finally, AstR was required for A. baumannii to colonize the gut in a mouse model. Together, these results suggest that pathogenic Acinetobacter species evolved AstR to regulate ornithine catabolism, which is required to compete with the microbiota during gut colonization.

Year:

2025

Year:

2023

Year:

2021

Year:

2020

Collaborators (6)

Jimmy Orjala

-

UNITED STATES
View details

Joanna E. Burdette

Professor

University of Illinois Chicago (UIC)

UNITED STATES
View details

Eric J. N. Helfrich

Professor of Natural Product Genomics

Goethe University Frankfurt

GERMANY
View details

Andrew P. Riley

University of Illinois Chicago (UIC)

UNITED STATES
View details

Joseph Gerdt

Assistant Professor

Indiana University Bloomington

UNITED STATES
View details

Francis Alonzo

University of Illinois Chicago (UIC)

UNITED STATES
View details